logo-large
  • Browse Categories

Publications by authors named "David R Bolin"

Claim this Profile
I
Inhibition of IRF5 cellular activity with cell-penetrating peptides that target homodimerization.
Jaspreet Banga, Dinesh Srinivasan, Chia-Chi Sun, Cherrie D Thompson, Francesca Milletti, David R Bolin

Sci Adv· May 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fragment-Based Drug Design of Novel Pyranopyridones as Cell Active and Orally Bioavailable Tankyrase Inhibitors.
Javier de Vicente, Parcharee Tivitmahaisoon, Pamela Berry, David R Bolin, Daisy Carvajal

ACS Med Chem Lett· September 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxazole- and imidazole-based Ser-Leu dipeptide mimetics in potent inhibitors of antigen presentation by MHC class II DR molecules.
Ramakanth Sarabu, David R Bolin, Robert Campbell, Joel R Cooper, Donald Cox

Drug Des Discov· April 2003


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: